Our objective is to discover, validate and target novel pathomechanisms and molecular signals for the development of personalized preventive and therapeutic strategies for diabetes, obesity and co-morbidities such as cancer and cardiovascular disease. The IDO currently comprises 14 research groups (including 4 Junior Research Groups) and the Neurobiology Research Unit headed by Dr. Pfluger. The IDO is part of the Helmholtz Diabetes Center (HDC). 

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.